BNP PARIBAS FINANCIAL MARKETS - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 95 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$1,195,438
+7.6%
68,822
-12.7%
0.00%
+100.0%
Q2 2023$1,110,560
-18.4%
78,875
-37.7%
0.00%
-50.0%
Q1 2023$1,361,635
+159.7%
126,546
+261.6%
0.00%
+100.0%
Q4 2022$524,285
-99.6%
34,999
+224.3%
0.00%
Q3 2022$138,569,000
-15.6%
10,792
-36.3%
0.00%
Q2 2022$164,149,000
-73.0%
16,940
-72.3%
0.00%
-100.0%
Q1 2022$608,298,000
-9.2%
61,197
+7.5%
0.00%0.0%
Q4 2021$669,807,000
+944.0%
56,908
+910.3%
0.00%
Q3 2021$64,160,000
+328.8%
5,633
+424.5%
0.00%
Q2 2021$14,961,000
-76.9%
1,074
-69.3%
0.00%
Q1 2021$64,766,000
+18.8%
3,499
+13.4%
0.00%
Q4 2020$54,512,000
-44.3%
3,085
-51.7%
0.00%
Q3 2020$97,895,000
+177.0%
6,390
+360.7%
0.00%
Q2 2020$35,341,000
-49.6%
1,387
-69.4%
0.00%
Q1 2020$70,062,000
+182.5%
4,526
+101.9%
0.00%
Q4 2019$24,797,000
+31.5%
2,242
+1.2%
0.00%
Q3 2019$18,858,000
-9.4%
2,216
+44.2%
0.00%
Q2 2019$20,811,000
-57.1%
1,537
-42.8%
0.00%
Q1 2019$48,491,000
+691.8%
2,685
+1131.7%
0.00%
Q4 2018$6,124,000
+74.0%
218
+58.0%
0.00%
Q3 2018$3,519,0001380.00%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q2 2022
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,025,000$12,064,0002.56%
GREAT POINT PARTNERS LLC 536,738$6,317,0001.40%
Endurant Capital Management LP 244,125$2,873,0000.69%
HHLR ADVISORS, LTD. 2,920,023$34,369,0000.53%
Integral Health Asset Management, LLC 140,000$1,648,0000.46%
Spearhead Capital Advisors, LLC 235,024$2,766,0000.33%
Jackson Creek Investment Advisors LLC 77,069$907,0000.32%
RICE HALL JAMES & ASSOCIATES, LLC 712,807$8,390,0000.30%
Parkman Healthcare Partners LLC 113,644$1,338,0000.30%
Birchview Capital, LP 30,000$353,0000.23%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders